You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: February 29, 2020

DrugPatentWatch Database Preview

Litigation Details for Idenix Pharmaceuticals LLC v. Gilead Pharmasset LLC (D. Del. 2014)

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Idenix Pharmaceuticals LLC v. Gilead Pharmasset LLC (D. Del. 2014)

Docket   Start Trial Date Filed 2014-01-29
Court District Court, D. Delaware Date Terminated
Cause 35:0146 Review of Board of Patent Appeals Decision Assigned To Leonard Philip Stark
Jury Demand Plaintiff Referred To
Patents 10,029,011; 10,029,015; 10,030,051; 10,030,059; 10,041,044; 10,046,000; 10,046,031; 10,046,056; 10,047,033; 4,012,039; 4,027,019; 5,001,048; 5,010,010; 6,011,020; 6,031,003; 6,031,007; 7,034,007; 8,013,002; 8,039,009; 8,039,010; 8,044,046; 8,048,017; 8,048,035; 8,058,052; 9,000,021; 9,000,038; 9,020,056; 9,022,022; 9,023,001; 9,024,007; 9,028,005; 9,035,031; 9,035,033; 9,040,034; 9,040,039; 9,056,052; 9,056,057; 9,056,059
Attorneys Andrew Colin Mayo; AnnaMartina Tyreus Hufnal; Anthony M. Insogna; Barbara R. Rudolph; Bradley W. Harrison; Calvin P. Griffith; Douglas Edward McCann; Elizabeth M. Flanagan; Gregory Robert Booker; Jennifer L. Swize; Jeremy Clark; John G. Day; John M. Michalik; Joseph B. Warden; Lauren E. Maguire; Lisa L. Furby; Lorie Ann Morgan; Michael A. Morin; Michael P. Kelly; Michael S. Weinstein; Rebecca Charnas Grant; Robert F. Shaffer; Robert M. Oakes; Ryan B. McCrum; Santosh Victor Coutinho; Stephanie E. Parker; Steven J. Balick; Tamara Fraizer; Tasha M Francis; Tharan Gregory Lanier; Thomas E. Friebel; William Chad Shear; William Raich
Firms Delaware Department of Justice; Fish & Richardson P.C.; Jeremy Clark
Link to Docket External link to docket
Small Molecule Drugs cited in Idenix Pharmaceuticals LLC v. Gilead Pharmasset LLC
Biologic Drugs cited in Idenix Pharmaceuticals LLC v. Gilead Pharmasset LLC

Details for Idenix Pharmaceuticals LLC v. Gilead Pharmasset LLC (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2017-02-27 403 period of over three years. I will show you the 04:12:39 23 evidence on this. And not once could they…is a patent case. As you heard on the 02:56:25 2 video, a patent is property. A patent is property…Idenix's patent and 04:10:15 8 what is in their patent and what is not in their patent. 04:10:20…They do not have the sample patent in them. 08:36:40 2 They have the patent from this case and the preliminary… never been in a patent 08:57:31 9 case where a jury wasn't told the patents were presumed 08 External link to document
2017-02-27 404 Sommadossi - direct 10:29:15 1 a Pharm.D degree at the University of Marseille…after getting the patent yesterday. The patent is 10:08:31 23 the Pharmasset patent. 10:08:34 24 … I called our patent, outside patent 11:46:33 22 lawyer, and asked to draft a patent application, … Okay. Is your patent a method patent or a 03:25:24 6 compound patent? 03:25:25 7 A. …in the Patent Office that a certain amount of 09:33:18 24 time after you file for a patent, it gets External link to document
2017-02-27 405 : Okay. So he writes to you, 'Here 10:29:11 22 are the facts' -- I'm at the second…02:29 21 U.S. patent. 04:02:30 22 Q. There were three patents or patent applications from…two other patent 04:02:39 25 applications. There were patents that were in the Patent …;'054 patent," U.S. Patent No. 7,608,597, the 04:14:55 2 "'597 patent," and…doesn't change as patents, different 04:16:19 2 patents come off patent. Those license External link to document
2017-02-27 407 code or 04:27:18 15 maintain your cells. 04:27:19 16 Nucleosides can be -- drugs…12 patent on a compound, a composition and matter patent and a 11:00:40 13 method patent? 11:00… is the patent application that -- I mean the 03:36:38 25 patent that came from the patent application…#39;597 patent at issue in 11:00:26 7 this case? 11:00:27 8 A. Reviewed the patent? 11:00…withdraw that. A compound 11:00:54 21 patent is a patent that claims on just the structure of the External link to document
2017-02-27 408 59 7 "Question: Okay. 10:46:00 8 "Answer: We didn'…to note, the patents in 08:38:14 18 California are obviously different than the patents that are 08…awarded any patents for your invention? 09:42:03 15 A. Yes. I was awarded six U.S. patents for that…that there are patents that can cover 09:51:44 13 the compound and then different patents that can cover…should look at Idenix's 11:18:01 23 patent or patent application to gain knowledge about how to External link to document
2017-02-27 409 number. It's the chart, Mr. Farrell, that 10:29:11 23 is about four pages or five pages from the…45:36 2 patents may resemble the patents in suit, therefore, the 01:45:36 3 patent in suit is …started to raise this patent, if your 01:45:37 4 patent is good, our patent is good. That …Question: The patent -- in you answer, the 02:59:36 13 patent being the Pharmasset patent? 02:59:36 …the Merck '224 patent, its predecessor 04:44:31 17 patent, the '395 patent, and the 1960 article External link to document
2017-02-27 411 01:10:27 10 can't go close to them. 01:10:29 11 So for most studies it's…the '597 patent -- the U.S. Patent Examiner actually 10:39:16 7 cited a Merck patent against the…the Merck patent 09:12:32 8 application. 09:12:33 9 Q. Is that the Merck patent application…Because the '597 patent was issued by the United 09:21:53 15 States Patent and Trademark Office…18 4 I'm sorry -- the Idenix patent, the '597 patent disclosure; 09:26:21 5 right? 09 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.